Yahui Tian

发表

Pharmacophore-Based 3D-QSAR Modeling, Virtual Screening and Molecular Docking Analysis for the Detection of MERTK Inhibitors with Novel Scaffold.

Suwen Zhou, Lu Zhou, Ruguo Cui, 2016, Combinatorial chemistry & high throughput screening.

GATA6 Exerts Potent Lung Cancer Suppressive Function by Inducing Cell Senescence

Xiaolong Fu, Yahui Tian, Guandi Zeng, 2020, Frontiers in Oncology.

Expression of histone deacetylase-1 and p300 in aristolochic acid nephropathy models

Yahui Tian, Guojuan Wu, Zhongwen Zhang, 2014, Toxicology mechanisms and methods.

Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathy

Guoying Wu, X-B Dong, Yahui Tian, 2015, Toxicology mechanisms and methods.

In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis

H. Ji, Luonan Chen, Kwok-Kin Wong, 2018, Proceedings of the National Academy of Sciences.

Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors

Chenqi Xu, C. Dong, Yahui Tian, 2020, EMBO molecular medicine.

Therapies after first-line afatinib in patients with EGFRm+ NSCLC in Japan: retrospective analysis of LUX-Lung 3.

K. Kiura, I. Okamoto, N. Yamamoto, 2020, Future oncology.

Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition

Xin Hu, H. Ji, Qingsong Liu, 2019, Nature Communications.

Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition

Xin Hu, H. Ji, Qingsong Liu, 2019, Nature Communications.

A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China

Jing Zhu, Ying Cheng, Yi-long Wu, 2022, Targeted Oncology.

Discovery of novel NAMPT inhibitors based on pharmacophore modeling and virtual screening techniques.

Xiaoli Li, Qianying Yi, Lu Zhou, 2015, Combinatorial chemistry & high throughput screening.

Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFRm+ non-small-cell lung cancer.

Hanxiao Chen, H. Bai, Yahui Tian, 2022, Future oncology.

Identification of Novel IRAK-4 Inhibitors Through Pharmacophore Modeling, Atom-based 3D-QSAR, Docking Strategies and Molecular Dynamics Simulation

Lu Zhou, Yahui Tian, Rong You, 2016 .

Identification of Potential Mps1 Inhibitors Through Multiple Pharmacophore- based Virtual Screening and Molecular Docking

Suwen Zhou, Lu Zhou, Yahui Tian, 2015 .